Go to the list of all blogs
Dem Sem's Avatar
published in Blogs
Aug 29, 2023
Smart Moves: Trader Robot Boosts $SAVA by +6.28% Last Week

Smart Moves: Trader Robot Boosts $SAVA by +6.28% Last Week

The latest triumph comes from the "Swing trader: Deep Trend Analysis (TA)" AI trading bots, which have earned the moniker of "bot factories" due to their impressive performance. These bots recently executed a remarkable feat by generating a substantial gain of +6.28% while trading SAVA over the past week. This success story underscores the growing role of AI in shaping the landscape of modern trading.

RSI Oscillator Signals Positive Shift for SAVA

One of the pivotal indicators that garnered attention during SAVA's recent trading activity is the Relative Strength Index (RSI) Oscillator. The RSI is a widely used technical indicator that helps traders assess the momentum and potential direction of a stock's price movement. On August 22, 2023, the RSI Oscillator for SAVA emerged from oversold territory. This event serves as a noteworthy signal that the stock might be transitioning from a downward trend to an upward trajectory.

For traders, this development holds strategic significance. The emergence of the RSI from oversold territory often triggers a bullish sentiment, as it suggests that the stock has been oversold and might be due for a rebound. Consequently, traders may consider purchasing the stock or exploring call options to capitalize on the anticipated upswing.

To gain deeper insights into the potential outcome, the AI trading platform, referred to as the A.I.dvisor, undertook an examination of historical instances similar to the current RSI movement. The analysis revealed that out of 26 cases where the RSI left oversold territory, the stock experienced an upward movement in 24 instances. This compelling historical precedent translates to an impressive 90% probability of a positive price movement following the RSI transition.

Earnings Report Overview

Beyond the technical indicators, understanding the company's financial performance is crucial for comprehensive analysis. SAVA's most recent earnings report, released on August 03, provided a snapshot of its financial health. The report disclosed an earnings per share (EPS) of -62 cents, which fell short of the estimated -58 cents. While this represents a negative deviation from the estimate, it is important to note that EPS figures are subject to various external factors and market dynamics that can influence their outcomes.

In terms of market capitalization, SAVA boasts 1.31 million outstanding shares, leading to a current market capitalization of approximately $766.37 million. This valuation is an essential metric that offers investors and traders insights into the company's size and value within the market.

Summary

The recent success of AI trading bots, particularly those integrated into the "Swing trader: Deep Trend Analysis (TA)" platform, highlights the growing capabilities of artificial intelligence in the trading landscape. The +6.28% gain achieved while trading SAVA serves as a testament to the potential of AI-driven strategies.

Moreover, the shift of SAVA's RSI Oscillator from oversold territory holds promise for traders looking to capitalize on potential price upswings. Backed by a historical track record of 90% accuracy in predicting upward movements after similar RSI shifts, traders may find this technical signal a valuable addition to their decision-making toolkit.

Related Ticker: FLNA

Contributor

Dem Sem's AvatarDem Sem|Expert

FLNA in +23.61% Uptrend, rising for three consecutive days on September 29, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where FLNA advanced for three days, in 191 of 238 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 53 of 67 cases where FLNA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.

The Moving Average Convergence Divergence (MACD) for FLNA just turned positive on September 22, 2026. Looking at past instances where FLNA's MACD turned positive, the stock continued to rise in 33 of 45 cases over the following month. The odds of a continued upward trend are 73%.

Bearish Trend Analysis

The 10-day RSI Indicator for FLNA moved out of overbought territory on September 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In 23 of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at 88%.

The Momentum Indicator moved below the 0 level on October 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FLNA as a result. In 76 of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 87%.

FLNA moved below its 50-day moving average on October 05, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for FLNA crossed bearishly below the 50-day moving average on October 06, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 88%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FLNA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.

FLNA broke above its upper Bollinger Band on September 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for FLNA entered a downward trend on September 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 32 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.648) is normal, around the industry mean (26.780). P/E Ratio (0.000) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.320) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating steady price growth. FLNA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FLNA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

Notable companies

The most notable companies in this group are Moderna (NASDAQ:MRNA), Regeneron Pharmaceuticals (NASDAQ:REGN), Incyte Corp (NASDAQ:INCY), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), Nektar Therapeutics (NASDAQ:NKTR), Sarepta Therapeutics (NASDAQ:SRPT), Novavax (NASDAQ:NVAX), Inovio Pharmaceuticals (NASDAQ:INO), Cel-Sci Corp (ASE:CVM).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.21B. The market cap for tickers in the group ranges from 58 to 133.74B. VRTX holds the highest valuation in this group at 133.74B. The lowest valued company is SEELQ at 58.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was -5%. For the same Industry, the average monthly price growth was -16%, and the average quarterly price growth was -5%. LONA experienced the highest price growth at 64%, while AVBP experienced the biggest fall at -49%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was -2%. For the same stocks of the Industry, the average monthly volume growth was 61% and the average quarterly volume growth was -15%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 78
Price Growth Rating: 65
SMR Rating: 93
Profit Risk Rating: 93
Seasonality Score: 1 (-100 ... +100)
View a ticker or compare two or three
FLNA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of novel drugs

Industry Biotechnology

Industry
Pharmaceuticals Other
Address
6801 N. Capital of Texas Highway
Phone
+1 512 501-2444
Employees
20
Web
https://www.filanatx.com
Interact to see
Advertisement
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
I've always been impressed by how Visa (V) commands the global payments landscape. As an open-loop network, it connects issuers, acquirers, merchants, and consumers without issuing cards or extending credit itself. The VisaNet platform processes over 65,000 transactions per second across more than 200 countries, supporting a ~52% share of the global credit card market and ~60% of debit. This scale generates powerful network effects, where greater adoption benefits everyone involved and creates formidable barriers to entry.
Following the Kenvue consumer health spin-off, Johnson & Johnson has transformed into a focused healthcare leader, emphasizing Innovative Medicine (pharmaceuticals) and MedTech (devices). In my view, this repositioning sharpens the company's edge in high-margin areas such as oncology, immunology, neuroscience, cardiovascular, surgery, and vision, where its diversified portfolio and R&D efficiency provide clear competitive advantages.
I've long appreciated ASML Holding N.V.'s dominant position in the semiconductor lithography market. The company commands over 90% share in advanced deep ultraviolet (DUV) immersion systems and 100% in EUV lithography—the critical technology for chips below 7nm nodes used in AI, high-performance computing, and memory. This near-monopoly comes from decades of R&D investment, exclusive partnerships like Zeiss for optics, and a vast installed base that generates steady service revenue. From what I see, competitors such as Nikon and Canon remain far behind in EUV, sticking to mature nodes.
I've been watching Micron Technology (MU) closely through its recent volatility, which mirrors the semiconductor sector's heightened sensitivity to AI demand and supply constraints. The stock saw a sharp post-earnings sell-off tied to elevated capital expenditure plans, yet it has rebounded with surging DRAM prices—up 90-95%—and memory suppliers booked out for years. From what I see, broader tech optimism, including key partnerships and persistent supply tightness, is driving upward momentum. This positions MU as a pivotal player in high-bandwidth memory (HBM) for data centers. Trading near recent highs around $368, the shares highlight investor focus on Micron's critical role in the AI infrastructure expansion under these constrained industry conditions.
I've always appreciated how Mastercard (MA) maintains a commanding position in the global payments industry, processing transactions across 3.4 billion cards at 150 million merchant locations worldwide. The network effects here create a formidable moat—increased adoption by issuers, acquirers, and consumers just reinforces its dominance. What stands out to me is how Mastercard is evolving beyond a pure processor into a services-first platform. Value-added services (VAS)—covering cybersecurity, data analytics, and consulting—are now approaching 40% of revenues and growing at double the rate of traditional payments.
MU shares are declining approximately -6.00% in premarket trading on April 2, 2026, pulling back to roughly $353.70 from the prior session's close of $376.27. The primary catalyst is a sweeping new round of tariff announcements from the Trump administration, dubbed by markets as "Liberation Day 2.0," which has sparked a broad risk-off selloff across technology and semiconductor stocks
Shares of Robinhood Markets are down approximately 6.15% in Thursday's intraday session, trading around $65.80 after closing at $70.11 on April 1, 2026. Wolfe Research delivered a sharp blow by cutting its price target on HOOD by 30%, citing persistent weakness in crypto trading volumes as a core drag on revenue.
Shares of Iridium Communications (IRDM) surged approximately +11.00% in Thursday's session, rising from a prior close of $28.52 to an intraday high near $31.76. A broad-based equity market rally drove significant gains across communication and satellite sector stocks, as investor sentiment sharply reversed after days of macro-driven selling pressure tied to tariff fears.
AirSculpt Technologies, Inc. (AIRS) stands out as a leading provider of minimally invasive body contouring procedures through its Elite Body Sculpture brand. The company specializes in proprietary AirSculpt treatments that remove fat and tighten skin without general anesthesia. These include options like AirSculpt+, AirSculpt Smooth for cellulite reduction, and specialized fat transfer procedures such as Power BBL for Brazilian butt lifts, Up a Cup for breast enhancement, and Hip Flip for hourglass contouring. Based in Miami Beach, Florida, and founded in 2012, AIRS operates centers across the United States, Canada, and the United Kingdom.
ASRT stock surged +66% over the past 30 days, driven by strong Q4 2025 earnings beat and optimistic 2026 guidance highlighting Rolvedon growth. Over the past quarter, the stock rose +117%, fueled by improving gross margins, stable product demand, and analyst price target increases.
I've been following Advantage Solutions Inc. (ADV)closely as a key player in outsourced sales, marketing, merchandising, sampling, and retailer support services for consumer packaged goods (CPG) manufacturers and retailers across North America, Asia Pacific, and Europe. The company operates through three segments: Branded Services, Experiential Services, and Retailer Services. Its focus remains on optimizing in-store execution, boosting consumer engagement, and strengthening retail partnerships.
NCS Multistage Holdings, Inc. (NCSM) stands out as a leading provider of highly engineered products and support services that optimize oil and natural gas well construction, completions, and field development strategies. The company operates primarily in the United States, Canada, and internationally, with a focus on fracturing systems, enhanced oil recovery, well construction products, and tracer diagnostics.
MGNX stock surged +53% over the last 30 days, driven primarily by a positive Q4 earnings surprise and analyst upgrades. Over the past quarter, the stock rose +80%, reflecting recovery from early-year lows amid biotech sector volatility.
PENG shares are surging approximately +16% in today's session, trading around $20.42, up from a prior close of $17.60 The primary catalyst is a Q2 fiscal 2026 earnings beat, with non-GAAP EPS of $0.52 surpassing the consensus estimate of $0.43 — a ~21% upside earnings surprise.
CareCloud, Inc. (CCLD) delivers cloud-based software-as-a-service (SaaS) solutions, revenue cycle management (RCM), and electronic health records (EHR) tailored for medical practices. The company's model centers on subscription platforms that handle practice management, patient engagement, and billing, with AI-driven tools adding efficiency.
Intellicheck, Inc. (IDN) focuses on on-demand digital identity validation solutions tailored for know your customer (KYC), fraud prevention, and age verification across North America. The company's business centers on software-as-a-service (SaaS) products such as IDN-Mobile, IDN-Portal, and IDN-Direct, which verify both digital and physical identities for industries like financial services, fintech, buy-now-pay-later (BNPL) providers, e-commerce, retail, and government agencies. In the competitive landscape of identity management software, Intellicheck occupies a solid niche with its reliable offerings, especially as fraud risks continue to escalate. From what I see, the recent profitability and SaaS revenue growth provide a strong foundation for the stock's performance, highlighting scalable potential in a market with clear demand.